Free Delivery Over $100
|
|
|||
|
||||
OverviewDementia is associated with a sizeable public health burden that is growing rapidly as the population ages. In addition to cognitive impairments, individuals with dementia often come to clinical attention because of symptoms of a behavioral disturbance (e.g., irritability, agitation, aggression) or psychosis. The burden on caregivers is substantial and is increased when dementia is associated with behavioral and psychological symptoms, and particularly with agitation or aggression. Treatment of psychotic symptoms and agitation in individuals with dementia has often involved use of antipsychotic medications. In recent years, the risks associated with use of these agents in the older adult population have become apparent. There has been a growing need to develop guidelines for appropriate use of antipsychotic medications in dementia. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia seeks to fulfill this need to improve the care of patients with dementia who are exhibiting agitation or psychosis. The guideline focuses on the judicious use of antipsychotic medications when agitation or psychosis occurs in association with dementia. It is intended to apply to individuals with dementia in all settings of care as well as to care delivered by generalist and specialist clinicians. The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. Findings from an expert opinion survey have also been taken into consideration in making recommendations or suggestions. In addition to reviewing the available evidence on use of antipsychotics in treating agitation or psychosis in patients with dementia, the guideline provides guidance to clinicians on implementing these recommendations to enhance patient care. Full Product DetailsAuthor: American Psychiatric AssociationPublisher: American Psychiatric Association Publishing Imprint: American Psychiatric Association Publishing Dimensions: Width: 21.60cm , Height: 1.20cm , Length: 27.90cm Weight: 0.708kg ISBN: 9780890426777ISBN 10: 0890426775 Pages: 218 Publication Date: 02 July 2016 Recommended Age: From 17 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsAcronyms/Abbreviations Introduction Chapter 1. Guidelines and Implementation Chapter 2. Rationale Chapter 3. Potential Benefits and Harms Chapter 4. Implementation Chapter 5. Quality Measurement Considerations Chapter 6. Guideline Development Process Glossary of Terms References Disclosures Individuals and Organizations That Submitted Comments Appendix A: Review of Available Evidence Appendix B: Expert Opinion Survey Data: ResultsReviewsThe American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia is a welcome addition to the library of any health care provider who treats older adults with dementia. It contains a rigorous review of the evidence-based literature on pharmacologic management specific to agitation and psychosis as behavioral symptoms in individuals with dementia.� -- Shilpa Srinivasan, M.D., DFAPA, Professor of Clinical Psychiatry and Director of the Geriatric Psychiatry Fellowship Program, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC� * Journal of Psychiatric Practice Vol. 23, No. 2 * The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia is a welcome addition to the library of any health care provider who treats older adults with dementia. It contains a rigorous review of the evidence-based literature on pharmacologic management specific to agitation and psychosis as behavioral symptoms in individuals with dementia. -- Shilpa Srinivasan, M.D., DFAPA, Professor of Clinical Psychiatry and Director of the Geriatric Psychiatry Fellowship Program, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC Journal of Psychiatric Practice Vol. 23, No. 2 The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia is a welcome addition to the library of any health care provider who treats older adults with dementia. It contains a rigorous review of the evidence-based literature on pharmacologic management specific to agitation and psychosis as behavioral symptoms in individuals with dementia. -- Shilpa Srinivasan, M.D., DFAPA, Professor of Clinical Psychiatry and Director of the Geriatric Psychiatry Fellowship Program, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC * Journal of Psychiatric Practice Vol. 23, No. 2 * Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
